These results suggest the presence of a functional genetic and epigenetic variant(s) of the neuromedin U gene influencing phenotypic variation in metabolic indices, encouraging further studies on NMU variants as biomarkers for risk assessment of cardio-metabolic disorders. This evidence concerns the gene NMU and Other metabolic disease.